Pricing

Issuance of FDA Black Box Warnings Strengthen Xarelto Lawsuit Plaintiffs’ Cases

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

TheProductLawyers.com reports on a South Florida resident whose husband died from internal bleeding while taking Xarelto, a new-generation blood thinner released on the market in 2011 after its approval by the U.S. Food and Drug Administration (FDA). The deceased's wife filed a lawsuit on his behalf against the manufacturers of the drug, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer Healthcare, stating they did not adequately warn consumers about the dangerous risks related to taking Xarelto, specifically the potential for significant and uncontrollable bleeding.

The plaintiff, in this case, alleges that Janssen and Bayer are responsible for her husband's death because of bleeding that doctors were unable to stop. He died from a subdural hemorrhage. The deceased was taking Xarelto to decrease his risk of having a stroke that he was susceptible to because of his heart condition, atrial fibrillation.

When Xarelto was released it was touted as being different than the traditional blood thinners that came before it because patients taking it did not have to be constantly monitored nor did they require special diets. The drug was very popular upon its release yet quickly became associated with serious side effects as plaintiffs began filing lawsuits claiming the drug caused episodes of uncontrollable bleeding.

Xarelto now is the focus of 2,800 lawsuits filed in federal courts all across the United States. It is also the subject of 550 more in a mass tort program in Philadelphia, PA.

Recent actions taken by the FDA also seem to verify the alleged risks associated with taking Xarelto with its issuance of two black box warnings for the drug. A black box warning is considered to be the harshest that can be given to a product before being ordered to remove it from the consumer market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About TheProductLawyers.com :

TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.

Contact TheProductLawyers.com:

Banville Law

165 West End Ave #1h,
New York, NY 10023

888-478-9711

Additional News Releases From TheProductLawyers.com:

November 30, 2016Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb

November 30, 2016Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings

November 30, 2016J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit

November 30, 2016Delaware Sees 10 New Talcum Powder Lawsuit Filings

November 29, 2016Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed

November 29, 2016Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother

November 29, 2016Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue

November 28, 2016FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings

November 28, 2016Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings

November 28, 2016More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts